# A Multiple Ascending Dose Study of COR388

> **NCT03418688** · PHASE1 · COMPLETED · sponsor: **Cortexyme Inc.** · enrollment: 33 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** COR388
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03418688
- **Lead sponsor:** Cortexyme Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2018-10-15
- **Final completion:** 2018-10-15
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03418688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03418688, "A Multiple Ascending Dose Study of COR388". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03418688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*